Indian Springs, AL, United States of America

Thomas R Tice

USPTO Granted Patents = 49 


 

Average Co-Inventor Count = 3.5

ph-index = 28

Forward Citations = 4,867(Granted Patents)


Location History:

  • Helena, AL (US) (1983)
  • Birmington, AL (US) (2001 - 2005)
  • Birmingham, AL (US) (1985 - 2009)
  • Indiana Springs, AL (US) (2016)
  • Indian Springs, AL (US) (2003 - 2021)

Company Filing History:

goldMedal18 out of 203 
 
Southern Research Institute
 patents
silverMedal8 out of 47 
 
Intersect Ent Gmbh
 patents
bronzeMedal7 out of 647 
 
The UAB Research Foundation (The University of Alabama at Birmingham)
 patents
44 out of 34 
 
Stolle Research & Development Corporation
 patents
54 out of 8,684 
 
US Government As Represented by the Secretary of the Army
 patents
64 out of 43 
 
Evonik Corporation
 patents
73 out of 8 
 
Clinuvel Pharmaceuticals Limited
 patents
82 out of 121 
 
Tepha, Inc.
 patents
91 out of 932 
 
Syntex (u.s.a.) Inc.
 patents
101 out of 30 
 
Innovata Biomed Limited
 patents
111 out of 212 
 
Cetus Corporation
 patents
121 out of 28 
 
Debiopharm S.a.
 patents
131 out of 4 
 
The Magrath Company
 patents
141 out of 1 
 
Brookwood Pharmaceuticals, Inc.
 patent
151 out of 5 
 
Surmodics Pharmaceuticals, Inc.
 patents
161 out of 232 
 
Surmodics, Inc.
 patents
172 out of 832,843 
Other
 patents
where one patent can have more than one assignee

Years Active: 1983-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Paranasal Sinus Conditions
Melanogenesis Induction
Microparticle Delivery
Pharmaceutical Compositions
Biodegradable Polymers
Bioactive Agents
Microencapsulation Techniques
Controlled-Release Formulations
Therapeutic Infections Treatment
Nerve Fiber Growth Stimulation
Drug Delivery Systems
Long-Acting Formulations
49 patents (USPTO):Explore Patents

Title: Thomas R Tice: A Pioneer in Medical Innovations

Introduction

Thomas R Tice, based in Indian Springs, Alabama (US), is a prolific inventor with an impressive portfolio of 49 patents. His work spans multiple fields, particularly in medical devices and therapeutic methods, making significant contributions to the healthcare industry.

Latest Patents

Among his latest innovations are two noteworthy patents. The first is titled "Device and Methods for Treating Paranasal Sinus Conditions," which outlines a sophisticated paranasal sinus device designed to alleviate sinus-related issues. This device comprises a cavity member, ostial member, and nasal portion, which work collaboratively to deliver an active agent for sustained release to treat conditions such as sinus inflammation resulting from functional endoscopic sinus surgery (FESS) and rhinosinusitis.

The second patent, "Methods of Inducing Melanogenesis in a Subject," describes cutting-edge techniques for promoting melanogenesis in human subjects. This method involves administering an alpha-MSH analogue in a manner that effectively induces melanogenesis in the epidermal tissue without causing homologous desensitization of the melanocortin-1 receptors.

Career Highlights

Throughout his career, Tice has been associated with prominent organizations, notably the Southern Research Institute and Intersect Ent GmbH. His dedication to research and development has led to substantial advancements in medical technology, enhancing patient care through innovative solutions.

Collaborations

In his journey, Thomas R Tice has collaborated with esteemed professionals like Jay K Staas and Richard M Gilley. These partnerships have fostered an environment of creativity and innovation, further pushing the boundaries of medical advances.

Conclusion

Thomas R Tice continues to be a driving force in the field of invention, with his patents reflecting his commitment to improving healthcare outcomes. His work not only showcases his ingenuity but also highlights the importance of collaboration in the innovation process. His contributions will undoubtedly have lasting impacts on both his peers and the patients who benefit from his inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…